BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32686704)

  • 1. Coronin 1C inhibits melanoma metastasis through regulation of MT1-MMP-containing extracellular vesicle secretion.
    Tagliatela AC; Hempstead SC; Hibshman PS; Hockenberry MA; Brighton HE; Pecot CV; Bear JE
    Sci Rep; 2020 Jul; 10(1):11958. PubMed ID: 32686704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function.
    Castagnino A; Castro-Castro A; Irondelle M; Guichard A; Lodillinsky C; Fuhrmann L; Vacher S; Agüera-González S; Zagryazhskaya-Masson A; Romao M; El Kesrouani C; Noegel AA; Dubois T; Raposo G; Bear JE; Clemen CS; Vincent-Salomon A; Bièche I; Chavrier P
    Oncogene; 2018 Dec; 37(50):6425-6441. PubMed ID: 30065298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF1α and HIF2α independently activate SRC to promote melanoma metastases.
    Hanna SC; Krishnan B; Bailey ST; Moschos SJ; Kuan PF; Shimamura T; Osborne LD; Siegel MB; Duncan LM; O'Brien ET; Superfine R; Miller CR; Simon MC; Wong KK; Kim WY
    J Clin Invest; 2013 May; 123(5):2078-93. PubMed ID: 23563312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
    Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
    Sandri S; Faião-Flores F; Tiago M; Pennacchi PC; Massaro RR; Alves-Fernandes DK; Berardinelli GN; Evangelista AF; de Lima Vazquez V; Reis RM; Maria-Engler SS
    Pharmacol Res; 2016 Sep; 111():523-533. PubMed ID: 27436149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
    Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.
    Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C
    J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
    Dankort D; Curley DP; Cartlidge RA; Nelson B; Karnezis AN; Damsky WE; You MJ; DePinho RA; McMahon M; Bosenberg M
    Nat Genet; 2009 May; 41(5):544-52. PubMed ID: 19282848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
    Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
    Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.
    Marusak C; Thakur V; Li Y; Freitas JT; Zmina PM; Thakur VS; Chang M; Gao M; Tan J; Xiao M; Lu Y; Mills GB; Flaherty K; Frederick DT; Miao B; Sullivan RJ; Moll T; Boland GM; Herlyn M; Zhang G; Bedogni B
    Clin Cancer Res; 2020 Nov; 26(22):6039-6050. PubMed ID: 32820016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
    Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
    Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Coronin-1C disrupts Rac1 activation and impairs tumorigenic potential in hepatocellular carcinoma cells.
    Wang ZG; Jia MK; Cao H; Bian P; Fang XD
    Oncol Rep; 2013 Mar; 29(3):1066-72. PubMed ID: 23292607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells.
    Tomari T; Koshikawa N; Uematsu T; Shinkawa T; Hoshino D; Egawa N; Isobe T; Seiki M
    Cancer Sci; 2009 Jul; 100(7):1284-90. PubMed ID: 19432894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation.
    Wu L; Peng CW; Hou JX; Zhang YH; Chen C; Chen LD; Li Y
    J Exp Clin Cancer Res; 2010 Feb; 29(1):17. PubMed ID: 20181269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation.
    Ma J; Tang X; Wong P; Jacobs B; Borden EC; Bedogni B
    J Biol Chem; 2014 Mar; 289(12):8442-9. PubMed ID: 24492617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.
    Bartolomé RA; Ferreiro S; Miquilena-Colina ME; Martínez-Prats L; Soto-Montenegro ML; García-Bernal D; Vaquero JJ; Agami R; Delgado R; Desco M; Sánchez-Mateos P; Teixidó J
    Am J Pathol; 2009 Feb; 174(2):602-12. PubMed ID: 19147814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive potential of melanoma cells correlates with the expression of MT1-MMP and regulated by modulating its association with motility receptors via N-glycosylation on the receptors.
    Ranjan A; Kalraiya RD
    Biomed Res Int; 2014; 2014():804680. PubMed ID: 25180193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.